학술논문
Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: A prospective, randomized, double-blind, three-parallel arm, multicenter, comparative study
Document Type
Article
Author
Ansquer, J.-C.; Guy, M.; Bekaert, I.; Hanefeld, M.; Simon, A.; Adam, S.; Arnould, M.; Letzelter, J.-M.; Marmor, P.; Assad, N.; Gariepy, J.; Baekelandt, J.; Battello, G.; Bostoen, G.; Danet, J.; De Marneffe, G.; De Ricke, C.; Dimon, B.; Engelen, M.; Fischer, S.; Flosi, M.; Fournier, H.; Hersen, B.; Freise, D.; Koch, M.; Oldenburg, W.; Hauck, P.; Mantz, S.; Mortelmans, J.; Naudts, I.; Rochet, J.P.; Saussez, A.; Scholz, G.; Timmermans, F.; Valensi, P.; Weber, H.-G.; Wieland, V.; Carewicz, O.
Source
In: American Journal of Cardiovascular Drugs . (American Journal of Cardiovascular Drugs, 2009, 9(2):91-101)
Subject
Language
English
ISSN
11753277